Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Catechol-O-methyltransferase”

15 trials

Showing 15 of 15 results

Not applicableTemporarily pausedNCT02179814
What this trial is testing

Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls

Who this might be right for
Bulimia NervosaEating DisordersDopamine+2 more
University of Bern 60
Testing effectiveness (Phase 2)Study completedNCT01568034
What this trial is testing

Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 10
Not applicableUnknownNCT03845920
What this trial is testing

Mod of Cognitive Flexibility by tDCS, Tyrosine Polymorphisms in the COMT Gene

Who this might be right for
Modulation of Cognitive Flexibility by Transcranial Direct Current Stimulation, Tyrosine Administration and Polymorphisms in the COMT Gene
Sheffield Hallam University 32
Testing effectiveness (Phase 2)Ended earlyNCT00548327
What this trial is testing

The Effects of Atomoxetine on Cognition and Brain Function Based on Catechol-O-methyltransferase(COMT) Genotype

Who this might be right for
SchizophreniaMemory DisordersCognition Disorders
National Institute of Mental Health (NIMH) 11
Early research (Phase 1)Study completedNCT02080715
What this trial is testing

Role of the Catechol-O-methyltransferase (COMT) in the Physiological Regulation of Vigilance

Who this might be right for
Healthy
University of Zurich 30
Not applicableUnknownNCT01075373
What this trial is testing

A Neurobiological Study on Heterogeneity of Schizophrenia: Genetic Variations and Neurobiological Differentiations

Who this might be right for
Schizophrenia
National Taiwan University Hospital 360
Testing effectiveness (Phase 2)UnknownNCT03273062
What this trial is testing

A Trial Evaluating Effects of COMT Inhibition in Patients With Acquired Brain Injury

Who this might be right for
Brain InjuriesBrain Injuries, TraumaticBrain Injury, Chronic
Sheppard Pratt Health System 16
Early research (Phase 1)Study completedNCT01520727
What this trial is testing

A Single Oral Ascending Dose Study of BIA 9-1067 in Healthy Male Subjects

Who this might be right for
Parkinson Disease
Bial - Portela C S.A. 64
Early research (Phase 1)Study completedNCT02101190
What this trial is testing

Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

Who this might be right for
Parkinson's Disease
Bial - Portela C S.A. 16
Not applicableUnknownNCT00664274
What this trial is testing

Relation of Catechol-O-methyltransferase (COMT) Genotype and Response to Cognitive Remediation Schizophrenia

Who this might be right for
Chronic Schizophrenia
Manhattan Psychiatric Center 142
Not applicableUnknownNCT00773760
What this trial is testing

MOR and COMT SNP Polymorphism and Pain

Who this might be right for
Pain Relief
East Tallinn Central Hospital 100
Not applicableActive Not RecruitingNCT05043103
What this trial is testing

Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

Who this might be right for
Advanced Parkinson Disease
Britannia Pharmaceuticals Ltd. 312
Very early researchStudy completedNCT00678730
What this trial is testing

Pharmacogenetics of Cannabinoid Response

Who this might be right for
COMT Gene Polymorphism
Yale University 72
Post-approval studies (Phase 4)Study completedNCT00373087
What this trial is testing

COMT Polymorphism and Entacapone Efficacy

Who this might be right for
Parkinson's Disease
Assistance Publique - Hôpitaux de Paris 60
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation